Eciskafusp Alfa
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Eciskafusp Alfa, covering 2025-06-16 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors [Phase 1]